Table 1.
Variable | MPM |
---|---|
Number of patients | 26 |
Age, yr. Median (range) | 68.5 (39–80) |
Gender | |
Male | 18 (69%) |
Female | 8 (31%) |
History of asbestos exposure (n = 21) | 13 (62%) |
Histology | |
Epithelioid | 17 (65%) |
Biphasic | 9 (35%) |
Clinical staging | |
I | 12 (46%) |
II | 9 (35%) |
III | 5 (19%) |
Multimodality treatment | |
Neoadjuvant chemotherapy | 9 (35%) |
Adjuvant chemotherapy | 7 (27%) |
Adjuvant radiotherapy | 6 (23%) |
Preoperative tumor PD-L1 > 1% | 14 (54%) |
Procedure | |
EPP | 6 (23%) |
P/D | 20 (77%) |
EPP extrapleural pneumonectomy, MPM malignant pleural mesothelioma, P/D pleurectomy/decortication, PD-L1 programmed cell death 1 ligand 1.